| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 300 | 60.615 | 117.316 | 63.568 | 30.940 | - | - | - |
| Total Income - EUR | - | - | 300 | 60.616 | 117.316 | 63.568 | 30.940 | - | - | - |
| Total Expenses - EUR | - | - | 7.096 | 52.445 | 104.746 | 72.583 | 29.012 | - | - | - |
| Gross Profit/Loss - EUR | - | - | -6.796 | 8.170 | 12.570 | -9.015 | 1.928 | - | - | - |
| Net Profit/Loss - EUR | - | - | -6.798 | 6.355 | 10.362 | -10.651 | 999 | - | - | - |
| Employees | - | - | 1 | 1 | 0 | 1 | 1 | - | - | - |
Check the financial reports for the company - Novastat Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 5.430 | 20.929 | 45.338 | 26.962 | 15.909 | - | - | - |
| Current Assets | - | - | 1.424 | 9.183 | 21.580 | 22.502 | 32.701 | - | - | - |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Receivables | - | - | 0 | 6.926 | 9.224 | 4.129 | 10.892 | - | - | - |
| Cash | - | - | 1.424 | 2.257 | 12.356 | 18.373 | 21.809 | - | - | - |
| Shareholders Funds | - | - | -6.755 | -265 | 10.102 | -740 | 276 | - | - | - |
| Social Capital | - | - | 44 | 54 | 53 | 52 | 51 | - | - | - |
| Debts | - | - | 13.609 | 30.377 | 59.423 | 54.054 | 48.334 | - | - | - |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Novastat Medical Srl